Gastric sleeve surgery side effects are an essential consideration for anyone exploring this form of bariatric treatment on the NHS. Sleeve gastrectomy permanently removes around 75–80% of the stomach, offering significant health benefits for eligible patients — but it also carries a range of short- and long-term risks that require careful management. From early post-operative nausea and dehydration to longer-term nutritional deficiencies and acid reflux, understanding what to expect before, during, and after surgery is vital. This article outlines the key side effects, serious complications, and evidence-based guidance to help patients and clinicians make fully informed decisions.

What Is Gastric Sleeve Surgery and How Is It Performed on the NHS?

Gastric sleeve surgery (sleeve gastrectomy) removes 75–80% of the stomach laparoscopically, leaving a banana-shaped pouch. NHS eligibility follows NICE guideline CG189, typically requiring a BMI of 40+ or 35–39.9 with an obesity-related condition.

Gastric sleeve surgery, medically known as sleeve gastrectomy, is a form of bariatric (weight-loss) surgery in which approximately 75–80% of the stomach is surgically removed, leaving a narrow, sleeve-shaped pouch roughly the size of a banana. This significantly reduces the stomach's capacity, limiting food intake and promoting earlier feelings of fullness. The procedure also removes the fundus — the part of the stomach that produces most of the hunger hormone ghrelin — which may contribute to reduced appetite in many patients, although the overall effects on appetite and weight are multifactorial and can vary over time.

On the NHS, gastric sleeve surgery is typically performed laparoscopically (keyhole surgery) under general anaesthetic. Hospital stay is usually one to two nights, though this may vary depending on local enhanced recovery protocols and individual clinical factors. The procedure is carried out by a specialist bariatric surgical team and is generally considered irreversible, as the removed stomach tissue cannot be reattached.

Eligibility for NHS bariatric surgery is guided by NICE (CG189: Obesity: identification, assessment and management), which recommends surgery for adults with a BMI of 40 or above, or a BMI of 35–39.9 alongside a significant obesity-related health condition such as type 2 diabetes or hypertension. For people with type 2 diabetes, NICE guideline NG28 also supports consideration of metabolic surgery at lower BMI thresholds — including BMI 30–34.9 in some circumstances. Additionally, for people of South Asian, Chinese, or Black African or Caribbean heritage, lower BMI thresholds for risk classification may apply (see NICE PH46), and clinicians should take this into account when assessing eligibility.

Access via the NHS typically requires completion of a structured Tier 3 weight management programme and a full multidisciplinary team (MDT) assessment before referral for Tier 4 surgical intervention. Local criteria and waiting times vary across NHS trusts and integrated care systems.

Understanding what the surgery involves is an important first step, but patients should also be fully informed about the range of side effects and potential complications that may arise — both in the short term and over the longer term.

Experiencing these side effects? Our pharmacists can help you navigate them →

Common Side Effects After Gastric Sleeve Surgery

Common side effects include nausea, vomiting, dehydration, fatigue, acid reflux, and hair thinning, most of which are temporary. Persistent vomiting requires urgent review due to the risk of stricture and thiamine deficiency.

As with any major surgical procedure, gastric sleeve surgery carries a range of common side effects, most of which are temporary and manageable with appropriate support. Being aware of these in advance helps patients prepare and respond appropriately during recovery.

Short-term side effects (in the days to weeks following surgery) may include:

• Nausea and vomiting — particularly common in the early post-operative period as the body adjusts to the smaller stomach

• Dehydration — a very common early risk, as reduced stomach capacity makes it difficult to maintain adequate fluid intake; patients should sip fluids regularly throughout the day and monitor urine colour (pale yellow indicates good hydration)

• Fatigue and low energy — a normal response to surgery and reduced caloric intake

• Pain or discomfort around the surgical site, typically managed with prescribed analgesia

• Shoulder-tip pain — caused by residual gas from laparoscopic insufflation; usually resolves within a few days

• Bloating and wind — common in the early post-operative weeks

• Acid reflux (gastro-oesophageal reflux disease, or GORD) — a notable side effect of sleeve gastrectomy; some patients experience new or worsened reflux symptoms post-operatively

• Constipation or changes in bowel habits — often related to dietary changes and reduced fibre intake

Dietary intolerances are also frequently reported. Many patients find that certain foods — particularly red meat, bread, rice, and carbonated drinks — become difficult to tolerate, at least initially. Food textures and tolerances often change significantly in the months following surgery.

Hair thinning (telogen effluvium) is another commonly reported side effect, typically occurring around three to six months post-surgery. This is largely attributed to rapid weight loss and nutritional deficiencies, particularly reduced protein and micronutrient intake. In most cases, hair regrowth occurs once nutritional status stabilises.

Important: Persistent vomiting or an inability to keep fluids down requires urgent clinical assessment, as this can indicate a stricture (narrowing of the sleeve) and also carries a risk of thiamine (vitamin B1) deficiency, which can cause serious neurological complications if untreated. Patients should contact their bariatric team or NHS 111 promptly if this occurs.

Whilst these side effects can be distressing, they are generally expected and manageable. Patients are advised to follow their bariatric team's dietary guidance closely and attend all scheduled follow-up appointments.

Serious Complications and When to Seek Medical Advice

Serious complications include staple line leak, internal bleeding, blood clots, and stricture — all requiring prompt medical attention. Call 999 for severe chest pain, collapse, or signs of sepsis; contact NHS 111 for persistent vomiting or worsening abdominal pain.

Although gastric sleeve surgery has a relatively low mortality rate in specialist UK centres (as reported by the National Bariatric Surgery Registry, NBSR), serious complications can occur and require prompt medical attention. Patients and their carers should be aware of the warning signs that necessitate urgent review.

Serious complications may include:

• Staple line leak — one of the most significant risks, occurring when the surgical join in the stomach fails to seal properly, potentially leading to infection or sepsis. Symptoms include severe abdominal pain, fever, persistent rapid heart rate, shoulder-tip pain, and feeling generally unwell

• Bleeding — either internally or at the surgical site

• Blood clots (deep vein thrombosis or pulmonary embolism) — a risk with any major surgery; patients are typically given anticoagulant medication and compression stockings, and are encouraged to mobilise early to reduce this risk

• Stricture or narrowing of the sleeve, causing persistent vomiting or difficulty swallowing

• Intra-abdominal abscess — a collection of infection within the abdomen, which may develop following a leak or other complication

• Incisional hernia — a recognised longer-term complication at laparoscopic port sites

• Gallstones — rapid weight loss significantly increases the risk of gallstone formation in the months following surgery; some centres consider prophylactic treatment (see the long-term effects section)

• Worsening or new-onset GORD — in some cases severe enough to require further surgical intervention, such as conversion to a Roux-en-Y gastric bypass

Call 999 immediately if you experience:

• Severe chest pain or acute shortness of breath

• Collapse or loss of consciousness

• Signs of sepsis: high temperature (or feeling very cold and shivery), rapid heart rate, confusion, or mottled skin

Contact NHS 111 or attend A&E if you experience:

• Severe or worsening abdominal pain

• Temperature above 38°C that does not settle

• Persistent vomiting preventing fluid intake

• Signs of wound infection (redness, swelling, discharge)

Longer-term complications can include nutritional deficiencies, psychological difficulties, and, in some cases, weight regain. Any concerns following discharge should be directed to the bariatric team in the first instance. Early intervention significantly improves outcomes.

Long-Term Effects on Nutrition, Digestion and Lifestyle

Long-term risks include deficiencies in vitamin B12, iron, vitamin D, calcium, and thiamine, requiring lifelong supplementation and annual blood monitoring. Lifestyle changes including avoiding pregnancy for 12–18 months post-surgery and awareness of increased alcohol sensitivity are also essential.

The long-term effects of gastric sleeve surgery extend well beyond weight loss and require ongoing attention to nutrition, digestion, and overall lifestyle. Because the stomach's capacity is permanently reduced, patients must adapt their eating habits for life.

Nutritional deficiencies are among the most clinically significant long-term concerns. Reduced food intake and altered digestion can lead to deficiencies in:

• Vitamin B12 — essential for nerve function and red blood cell production; long-term replacement is often required, frequently as three-monthly intramuscular (IM) injections, in line with BOMSS (British Obesity and Metabolic Surgery Society) guidance

• Iron — particularly relevant for pre-menopausal women, with deficiency potentially leading to anaemia; supplementation should be guided by blood results

• Vitamin D and calcium — important for bone health; long-term deficiency increases the risk of osteoporosis; supplementation is typically with a combined calcium with vitamin D preparation, adjusted according to monitoring results

• Thiamine (vitamin B1) — deficiency can develop rapidly in patients with persistent vomiting and may cause serious neurological complications (including Wernicke's encephalopathy); urgent clinical review is essential if prolonged vomiting occurs

• Folate and zinc — also commonly affected

Lifelong vitamin and mineral supplementation is recommended for all patients following bariatric surgery, in line with NHS, NICE, and BOMSS guidance. Blood monitoring should follow a structured schedule — typically at three and six months post-operatively, then at least annually thereafter. A standard panel includes full blood count (FBC), renal and liver function, ferritin, folate, vitamin B12, vitamin D, calcium, and parathyroid hormone (PTH), with zinc, copper, and selenium checked as clinically indicated. Patients should not self-prescribe supplements without guidance from their bariatric team, as excessive intake of certain nutrients can also be harmful.

Gallstones are a recognised risk following rapid weight loss. Some NHS centres consider short-term prophylaxis with ursodeoxycholic acid in the months after surgery; patients should ask their bariatric team about local policy.

Digestive changes are also common. Many patients experience altered bowel habits, increased sensitivity to fatty or sugary foods, and symptoms such as nausea, bloating, and diarrhoea after eating certain foods. Dumping syndrome — characterised by rapid gastric emptying — is more commonly associated with gastric bypass but can occasionally occur after sleeve gastrectomy.

Lifestyle considerations:

• Smoking should be stopped before and after surgery; smoking increases the risk of staple line complications and ulceration

• Alcohol — sensitivity to alcohol typically increases significantly after sleeve gastrectomy due to altered absorption; there is also a recognised risk of alcohol use disorder developing after bariatric surgery, and patients should be aware of this and seek support if concerned

• Pregnancy and contraception — women of childbearing age are advised to avoid pregnancy for at least 12–18 months after surgery, when weight loss is most rapid and nutritional status may be unstable. Reliable contraception should be discussed with the GP or bariatric team; oral contraceptives may be less reliably absorbed in the early post-operative period

From a broader lifestyle perspective, patients are encouraged to adopt long-term behavioural changes including regular physical activity, mindful eating, and psychological support where needed. The relationship with food often changes significantly, and some individuals may develop disordered eating patterns post-surgery. Access to psychological support through the bariatric MDT is an important component of long-term care.

Patients and healthcare professionals should report any suspected adverse effects from medicines used around surgery (including supplements and prescribed medications) via the MHRA Yellow Card scheme (available at yellowcard.mhra.gov.uk).

Managing Side Effects: NHS and NICE Guidance

Management follows a structured MDT approach per NICE CG189, including staged dietary progression, PPI therapy for reflux, and prompt nutritional supplementation guided by blood results. Psychological support and GP-coordinated annual monitoring are key components of long-term care.

Effective management of gastric sleeve surgery side effects relies on a structured, multidisciplinary approach. NICE guideline CG189 and associated guidance emphasise that bariatric surgery should be delivered within a specialist MDT setting, including input from dietitians, psychologists, specialist nurses, and surgeons — both before and after the procedure. BOMSS provides additional UK-specific guidance on postoperative dietary management and nutritional supplementation.

Dietary management is central to recovery. Post-operative dietary progression typically follows a staged approach, though the exact timings vary between NHS centres and patients should always follow their own bariatric team's instructions:

• Stage 1 (approximately weeks 1–2): Fluids only

• Stage 2 (approximately weeks 2–4): Puréed foods

• Stage 3 (approximately weeks 4–6): Soft foods

• Stage 4 (approximately week 6 onwards): Gradual reintroduction of solid foods

Patients are advised to eat slowly, chew thoroughly, avoid drinking fluids with meals, and stop eating as soon as they feel full. These habits help minimise nausea, vomiting, and discomfort. Sipping fluids consistently between meals is essential to prevent dehydration.

Not sure if this is normal? Chat with one of our pharmacists →

For acid reflux, proton pump inhibitors (PPIs) such as omeprazole are commonly prescribed in the post-operative period and may be required long term in some patients. If GORD symptoms are severe or persistent, further assessment by the bariatric team is warranted and conversion to a different procedure may occasionally be considered.

Nutritional supplementation should begin promptly after surgery. NHS bariatric services typically recommend a complete bariatric multivitamin, alongside additional vitamin D, calcium with vitamin D, and iron as indicated by blood results. Vitamin B12 replacement — often as three-monthly IM injections — is frequently required long term. Thiamine supplementation should be considered urgently in any patient with persistent vomiting. Supplement regimens should be tailored to individual blood results and reviewed regularly; patients should not adjust supplementation without guidance from their bariatric or primary care team.

Some centres prescribe short-term ursodeoxycholic acid following surgery to reduce the risk of gallstone formation during the period of rapid weight loss; patients should ask their team about local practice.

Psychological support, including cognitive behavioural therapy (CBT) or counselling, may be beneficial for patients experiencing emotional difficulties related to body image, eating behaviours, or adjustment to lifestyle changes. GPs play an important role in coordinating ongoing care — including annual blood monitoring after specialist discharge — and should be kept informed of any new or worsening symptoms.

Suspected adverse effects from any medicines or medical devices used in connection with surgery should be reported via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk).

Weighing the Risks and Benefits Before Gastric Sleeve Surgery

Gastric sleeve surgery offers significant improvements in type 2 diabetes, hypertension, and quality of life, but carries risks including weight regain and serious surgical complications. Shared decision-making with a GP and specialist bariatric team is essential before proceeding.

For eligible patients, gastric sleeve surgery can offer substantial and sustained health benefits. UK clinical evidence, including data from the National Bariatric Surgery Registry (NBSR), consistently demonstrates significant improvements in obesity-related conditions following sleeve gastrectomy, including:

• Type 2 diabetes — with remission or significant improvement in many patients

• Hypertension and cardiovascular risk factors

• Obstructive sleep apnoea

• Joint pain and mobility

• Mental health and quality of life

On average, patients can expect to lose a significant proportion of their excess body weight within the first 12–18 months, though individual outcomes vary. Long-term weight maintenance depends heavily on adherence to dietary and lifestyle changes.

However, the decision to proceed with surgery should never be taken lightly. The side effects and complications outlined throughout this article — ranging from common short-term discomforts to rare but serious surgical risks — must be carefully considered. Weight regain is possible over time, particularly if behavioural changes are not sustained.

Patients are strongly encouraged to:

• Attend all pre-operative assessments and educational sessions

• Engage openly with the MDT about expectations, concerns, and mental health

• Understand that surgery is a tool, not a cure — long-term success requires ongoing commitment

There is no single 'right' answer for every individual. Some patients may achieve meaningful health improvements through non-surgical interventions, including structured lifestyle programmes or pharmacological options. GLP-1 receptor agonists such as semaglutide are available on the NHS for weight management, subject to eligibility criteria set out in NICE technology appraisal TA875; however, access may be limited by local service capacity and supply, and not all patients will qualify.

Anyone considering gastric sleeve surgery should have a thorough, informed discussion with their GP and specialist bariatric team to ensure the decision is right for their individual circumstances, health needs, and long-term goals. Shared decision-making, with full consideration of personalised risks and benefits, is central to good care.

Frequently Asked Questions